A PKC-mediated backup mechanism of the MXXCW motif-linked switch for initiating tyrosine kinase activities  by Takeda, Kozue et al.
FEBS Letters 580 (2006) 839–843A PKC-mediated backup mechanism of the MXXCW motif-linked
switch for initiating tyrosine kinase activities
Kozue Takedaa,c, Yoshiyuki Kawamotoa,c, Yusuke Okunoa, Masashi Katoc,
Masahide Takahashib, Haruhiko Suzukia, Kenichi Isobea, Izumi Nakashimaa,c,*
a Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
b Department of Pathology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
c Research Institute of Life and Health Sciences, Chubu University, 1200 Matsumotocho, Kasugai 487-8501, Japan
Received 7 October 2005; revised 27 December 2005; accepted 2 January 2006
Available online 18 January 2006
Edited by Angel NebredaAbstract The cysteine in the M/IXXCW motif is conserved in
all but one (threonine in place of cysteine) of the human protein
tyrosine kinases (PTKs). We showed that all RET-PTC-1 mu-
tants in which the C in this motif (C376) was replaced with gly-
cine, lysine, threonine or serine lost their activity in vitro.
However, the C376T/S mutants showed normal tyrosine phos-
phorylation in vivo (in cells). Further analyses reveled that pro-
tein kinase C (PKC) initiated the activities of the C376T/S
mutants in cells. We conclude that the M/IXXCW motif-medi-
ated mechanisms which initiate PTK activities are partially re-
placed by a PKC-mediated mechanism.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The catalytic activities of protein tyrosine kinases (PTKs)
have been shown to be regulated by oxidative stress [1–3].
The c-RET proto-oncogene encodes a receptor-type PTK [4],
and rearrangement of this gene is found in human papillary
thyroid carcinoma (PTC) [5,6]. We have previously reported
that a small fraction of RET proteins formed S–S-bonded
dimers in cells in association with their activities [7,8]. The
replacement with alanine of one of the two cysteines (C)
conserved near the COOH end of the kinase domain in Lck
[9], v-Src [10] and RET [7] greatly diminished their catalytic
activities. However, because stabilities of these mutant pro-
teins were reduced, we could not evaluate the signiﬁcance of
this cysteine.
The alignment of the amino-acid sequences of 81 human
proteins registered as PTKs (excluding 22 proteins that have
dual kinase activities both for tyrosine and serine or threonine)
in Swiss-Prot (18/11/2004) has revealed that all of these PTKsAbbreviations: PTK, protein tyrosine kinase; PKC, protein kinase C;
PTC, papillary thyroid carcinoma; DMEM, Dulbecco’s modiﬁed
Eagle’s medium; CS, calf serum; MBP, myelin basic protein; GFX,
GF109203X
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doi:10.1016/j.febslet.2006.01.005have a kinase domain with the same basic structure [11]. We
found that the above-mentioned cysteine is in the M(80/81)/
I(1/81)-XXCW motif, which is present in all but one of the
81 human PTKs. These ﬁndings suggested that this cysteine
is crucial for PTKs.
The aim of this study was to determine whether RET mu-
tants in which the cysteine in the M/IXXCW motif is replaced
with polar or charged amino acids such as glycine, lysine, ser-
ine or threonine rather than with the non-polar alanine also
lose their activities. The results conﬁrmed our previous pro-
posal that an M/IXXCW motif-mediated redox-linked mecha-
nism is crucial for the activities of PTKs, and our present
results demonstrated for the ﬁrst time that this mechanism
can be partially replaced by a PKC-mediated mechanism in
mutants with a Cﬁ T(S) mutation.2. Materials and methods
2.1. Plasmid construction and transfection
The cDNA of RET-PTC-1 [6] or RET-PTC-1 in which cysteine 376
had been replaced with glycine (RET-PTC-1 C376G), lysine (C376K),
serine (C376S) or threonine (C376T) was inserted into an APtag-1 vec-
tor, as described previously [12]. Mutation was induced by polymerase
chain reaction. Each plasmid was transfected into NIH3T3 cells using
GenePROTER Transfection Reagent (Gene Therapy Systems).2.2. Western blotting, immunoprecipitation and kinase assay
Western blotting, immunoprecipitation and an in vitro RET kinase
assay were performed as described previously [8]. A non-radioactive
tyrosine kinase assay was performed using a Tyrosine Kinase Activity
Assay Kit (CHEMICON) in accordance with the manufacturer’s
instructions.2.3. Soft agar assay
Cells were seeded at a concentration of 2.5 · 104 cells/35-mm dish.
Bottom layers were made up of 0.72% agar in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM; Sigma–Aldrich) supplemented with 8% calf
serum (CS; HyClone). Cells were resuspended in a top layer made of
0.36% agar in 8% CS DMEM (±inhibitor).2.4. In vitro phosphorylation by PKC
Immunoprecipitated RET protein was incubated with 20 ng of puri-
ﬁed PKC (active PKC, mixture of a, b and c isoforms) (Upstate) at
30 C for 20 min in an assay buﬀer (20 mM 3-morpholino propanesulf-
onic acid, pH 7.2, 25 mM b-glycerophosphate, 1 mM Na3VO4, 1 mM
CaCl2, 0.25 mg/ml phosphatidylserine, 0.025 mg/ml diglycerides, 13
mM MgCl2, 1 mM dithiothreitol and 100 nM ATP).blished by Elsevier B.V. All rights reserved.
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3.1. The cysteine in the M/IXXCW motif plays a crucial role in
initiating PTK activity
We ﬁrst measured the basal kinase activities of extracellular
domain-deleted RET-PTC-1 (constitutively active as an onco-
gene product) and each mutant protein in which cysteine (non-
charged, polar amino acid) 376 in the M/IXXCW motif had
been replaced with glycine, threonine or serine (non-charged,
polar) or lysine (charged). As shown in Fig. 1, the activities
of all of the C376 mutants for both autophosphorylation
and phosphorylation of an exogenous substrate (MBP; myelin
basic protein), as measured by an in vitro kinase assay, were
drastically reduced compared with those of the original
RET-PTC-1 (A), whereas the RET expression levels were com-
parable (D). These ﬁndings, together with earlier results for
RET-PTC-1 in which C376 was replaced with alanine (non-
polar amino acid), indicate that the substitution of the cysteine
in this motif abolishes the kinase activities.
Unexpectedly, we found that C376-to-threonine (C376T)
and C376S mutants of RET-PTC-1, whose in vitro kinase
activities were impaired (Fig. 1A), displayed original levels ofFig. 1. RET-PTC-1 C376 mutants show drastically diminished activi-
ties in vitro with variable in vivo activities. Lysates from cells
transfected with RET-PTC-1 or RET-PTC-1 with a C376G, C376K,
C376T or C376S mutation were subjected to in vitro kinase assay (A)
or to Western blotting with anti-phospho-Ret [Tyr905] (Cell Signaling
Technology) (B), anti-phosphotyrosine (Upstate) (C) or anti-RET
(IBL) (D) antibody after immunoprecipitation with anti-RET anti-
body. Representative data of 3 clones of the transfectants which
yielded basically the same results are shown. pRET, autophosphory-
lated RET; pMBP, phosphorylated MBP.overall tyrosine phosphorylation (Fig. 1C) and Tyr294 phos-
phorylation (=Tyr905 of c-RET) (Fig. 1B) as the suggested
major autophosphorylation site [12] of RET in vivo, whereas
the RET-PTC-1 C376G and C376K showed no phosphoryla-
tion either in vitro or in vivo.
It is known that RET-PTC-1 expression induces cell trans-
formation as an oncogene. We next examined whether these
mutants can induce cell transformation. NIH3T3 cells trans-
fected with RET-PTC-1 C376T/S formed colonies in soft agar,
whereas C376G/K mutants failed to form colonies (Fig. 2).
These results indicated that RET-PTC-1 proteins with a
C376T/S mutation retained their structure and displayed their
activity in vivo, although they lacked kinase activities in vitro.Fig. 2. C376T/S mutants can induce cell transformation. NIH3T3 cells
transfected with RET-PTC-1 or RET-PTC-1 with a C376 mutation
were grown in soft agar. The cells were photographed after 2 weeks of
culturing (A). The number of colonies of the indicated cells was
determined (B). Each value is the mean of 3 dishes ± S.D. Bar: 0.2 mm.
Fig. 3. Demonstration of an MXXTW-K-linked backup mechanism.
(A–C) RET proteins were isolated from the lysates of NIH3T3 cells
that had been transfected with RET-PTC-1 or RET-PTC-1 with a
C376T, C376S or C376G mutation by immunoprecipitation with anti-
RET antibody. The beads bearing RET proteins after immunoprecip-
itation were incubated in the presence (+) or absence () of puriﬁed
active PKC. They were then washed and subjected to in vitro kinase
assay (A, top), to Western blotting with anti-phosphorylated Ret
[Tyr905] (B, top), with anti-phosphotyrosine (B, middle) or with anti-
RET antibody (B, bottom), or to non-radioactive tyrosine kinase assay
(C). Equal amounts of the cell lysates were used for the in vitro kinase
assay (A, top) and for the Western blotting with anti-RET antibody
(A, bottom). pRET, autophosphorylated RET. (D) NIH3T3 cells
transfected with RET-PTC-1 or RET-PTC-1 with a C376T or C376G
mutation were treated for 30 min with control media () or media
containing 100 nM PMA (+). Lysates of these cells were subjected to
Western blotting with anti-phospho-Ret [Tyr905] (top) or anti-RET
antibody (bottom). PKC activation was conﬁrmed by the data, which
showed that some of the PKC proteins were translocated from the
cytosol to the membrane (not shown). The representative data of 3
experiments which yielded basically the same results are shown
(A,B,D). Each value is the mean of 3 experiments ± S.D. (C).
*P < 0.05, t test.
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motif
In order to clarify the reason why C376T/S mutants show
dissociated in vivo and in vitro actions, we tested the hypoth-
esis that some elements persistently operate on RET in vivo (in
cells) but not on isolated RET in vitro for maintaining these
activities. In earlier studies, we have shown that kinase activ-
ities of some RET mutants with low activity levels were re-
stored through phosphorylation by Src in trans [13].
However, the activities of the C376T/S mutants were not re-
stored by v-Src (data not shown). We next examined the eﬀect
of PKC on the activities of RET-PTC-1 C376T/S. RET pro-
teins were isolated and subjected to an in vitro kinase assay
after they had been preincubated with puriﬁed activated
PKC. The levels of the overall phosphorylation of RET-
PTC-1 C376T or C376S, but not C987G, were found to be
upregulated by preincubation with PKC (Fig. 3A). The phos-
phorylation levels of RET-PTC-1 C376T or C376S that were
upregulated by the PKC preincubation were, however, by
far lower than those of the original RET-PTC-1, suggesting
that the demonstrated in vitro PKC eﬀect was much smaller
than the possibly corresponding in vivo eﬀect. The increase
in the overall phosphorylation levels of the kinase proteins
in the kinase assay does not necessarily indicate the upregula-
tion of phosphorylation at the tyrosine. MBP was not, how-
ever, suitable for use as a speciﬁc exogenous substrate in this
experiment, because MBP was found to work as a substrate
of PKC (data not shown) that might remain in the assay
system.
Next, we tried to compare the tyrosine phosphorylation lev-
els of RET kinases that had been preincubated with PKC be-
fore the kinase assay with that of RET kinases that had been
preincubated without PKC by performing immunoblotting
with anti-phosphotyrosine or phosphorylated Tyr905. How-
ever, we failed to demonstrate any statistically signiﬁcant in-
crease in the level of tyrosine phosphorylation of the RET
kinases preincubated with PKC (Fig. 3B), because the high le-
vel of background tyrosine phosphorylation possibly induced
by the supposed in vivo PKC eﬀect seems to have masked
the relatively small increase in the phosphorylation level
in vitro (Fig. 3A).
Lastly, we successfully demonstrated the PKC eﬀect on the
kinase activities of RET-PTC-1 C376T but not of RET-PTC-
1 C376G for upregulation, by comparing the levels of
in vitro tyrosine phosphorylation newly induced in the assay
system, using a tyrosine kinase-speciﬁc substrate peptide
(Fig. 3C).
The overall phosphorylation level of RET-PTC-1, which was
saturated under the exposure condition, as shown in Fig. 3A,
was also found to be upregulated following the in vitro PKC
preincubation when examined under a condition of lower
exposure (data not shown). However, this eﬀect of PKC did
not accompany any corresponding increase in the level of over-
all tyrosine or Tyr905 phsophorylation (Fig. 3B) or of the
phosphorylation of tyrosine kinase-speciﬁc substrate peptide
(Fig. 3C).
These results show that preincubation of the enzymes with
PKC partially restored the defect in the intrinsic kinase activity
in vitro of the C376S/T mutants, but not the defect in the activ-
ity of the C376G mutant, and suggest that a PKC-mediated
backup mechanism basically similar to that demonstrated
in vitro works in vivo to increase the levels of autophosphory-lation at the tyrosine and those of the kinase activities to those
shown in Fig. 1B and C by persistently operating the otherwise
inactive kinases. These results indicate not only that PKC
plays a critical role in the backup mechanism for the role of
cysteine in the M/IXXCW motif, but also that the molecular
integrity needed for the activity in vitro was retained in the
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an activator of PKC, increased the phosphorylation at Tyr294
in RET-PTC-1 C376T cells but not in parental RET-PTC-1 or
RET-PTC-1 C376G cells (Fig. 3D). The phosphorylation at
Tyr294 in RET-PTC-1 C376G was not detected at all in a con-
dition of higher exposure, although the protein expression level
of the C376G mutant shown in Fig. 3D was lower than that of
the C376T mutant or the parental RET-PTC-1.
We further investigated whether GF109203X (GFX) as a
speciﬁc PKC inhibitor aﬀects RET-PTC-1 C376T/S phosphor-
ylation in vivo. GFX treatment decreased the phosphorylation
at Tyr294 of the C376T mutant (Fig. 4A) and C376S (not
shown) but not that of the original RET-PTC-1 and the
C376G mutant (Fig. 4A). As shown in Fig. 4B, the transform-
ing activities of RET-PTC-1 C376T (Fig. 4) and C376S (not
shown) were reduced by the addition of GFX, whereas those
of the original RET-PTC-1 were not signiﬁcantly aﬀected by
the same treatment.Fig. 4. A PKC inhibitor decreases RET-PTC-1 C376T activity in vivo.
(A) NIH3T3 cells transfected with RET-PTC-1 or RET-PTC-1 with a
C376T or C376G mutation were treated for the indicated time with
control media () or media containing 2 lM GFX (bisindolylmale-
imide I; Calbiochem) (+). Lysates of these cells were subjected to
Western blotting with anti-phospho-Ret [Tyr905] (top) or anti-RET
antibody (bottom). The representative data of three experiments which
yielded basically the same results are shown. (B) NIH3T3 cells
transfected with RET-PTC-1 or RET-PTC-1 C376T were grown in
soft agar in the presence (+) or absence () of 2 lM GFX. The cells
were photographed after 2 weeks of culturing (B). The number of
colonies of the indicated cells was determined (C). Each value is the
mean of 3 dishes ± S.D. Bar: 0.2 mm. *P < 0.005, t test.The exact site of phosphorylation by PKC remains to be
clariﬁed. However, it has been reported that S/T-X-R/K se-
quences are PKC phosphorylation sites [14], and we noticed
that C376T/S mutants carry one of these sequences around
T/S376 as T/S-W-K. These ﬁndings suggest that the impaired
activities in vitro in the C376T/S mutants, but not those in
the C376G mutant, are partially repaired by PKC, which
potentially phosphorylates threonine or serine residues on
the MXXT/SW-K sequence, which is missing in the C387G
mutant and in the parental RET-PTC-1.
These results might explain why one exceptional PTK, FGR,
which carries the MXXTW-R sequence, survived even though
it was defective of the M/IXXCW motif. Correspondingly,
GFX treatment decreased the tyrosine phosphorylation of
Fgr (data not shown). This ﬁnding suggests that this PKC-
mediated mechanism works physiologically. It is speculated
that either an M/IXXCW-mediated or M/IXXTW-R/K-linked
backup mechanism works in vivo for maintaining enzyme
activities. When enzymes are transferred from cells to an
in vitro system, the cysteine-mediated mechanism might work
exaggeratedly because the isolated enzymes face an oxidizing
environment, whereas the backup mechanism cannot operate
because the enzymes are isolated from PKC and other cellular
elements.3.3. The mechanism mediated by the cysteine in the M/IXXCW
motif is redox-linked
We have previously shown that exposure of cells carrying
RET-PTC-1 to UV irradiation promotes RET activities in
close association with the redox reaction-linked dimerization
of RET proteins [7]. We thus examined whether cells bearing
RET-PTC-1 C376T, which lacks the conserved cysteine but
retains in vivo enzyme activity, are able to respond to oxida-
tive stress. Treatment of cells bearing the parental RET-PTC-
1 with H2O2 or UV resulted in the promotion of the tyrosine
phosphorylation of RET, in agreement with the earlier re-
sults. However, the same treatment barely raised the tyrosine
phosphorylation level of the C376T mutant (Fig. 5). These re-
sults demonstrate that the cysteine in the M/IXXCW motif
plays a redox-linked role in the regulation of PTK activities
in vivo.
The known tyrosine phosphorylation-dependent regulatory
mechanism does not seem to replace the mechanism mediated
by the cysteine in the M/IXXCW motif because the C376T/S
mutants failed to display any detectable activities in vitro even
though the tyrosine at the major phosphorylation site on these
mutants was phosphorylated by the demonstrated backup
mechanism in vivo. It is speculated that the cysteine in the
M/IXXCW motif, which is located at the a-H helix, works
as a redox-linked global switch for turning the tyrosine phos-
phorylation-dependent local switch on. This global switch
might be turned on through the oxidization of the cysteine in
this motif for S–S-bonded dimerization, as previously sug-
gested [7,8]. Intriguingly, Src family kinases are known to
carry a regulatory tyrosine, which is located downstream of
the M/IXXCW motif and works as a global switch [15]. The
present study further indicates that exceptional Cﬁ T mutants
survive because of the presence of a PKC-mediated backup
mechanism, which initiates the enzyme activity but is unable
to respond to oxidative stress for the redox-linked acceleration
of the once initiated activities.
Fig. 5. Oxidative stress induces tyrosine phosphorylation of RET-PTC-1 but not RET-PTC-1 C376T in vivo. NIH3T3 cells transfected with RET-
PTC-1 (left) or RET-PTC-1C376T (right) were treated for 5 min with control media () or media containing 10 mM H2O2 (+) or after sham () (A)
or 600 J/m2 UV irradiation (+) (C). RET proteins were immunoprecipitated with anti-RET antibody from lysates of these cells and were subjected to
Western blotting with anti-phosphotyrosine (top) or anti-RET antibody (bottom). Representative data of 3 experiments with basically the same
results are shown in A and C. The level of phosphorylation per protein amount was quantiﬁed by densitometry using Scion Image (shared NIH
software). Percent increase in phosphorylation was calculated, and the mean result of three experiments ± S.D is shown in B and D. Percent increase
in phosphorylation = % (phosphorylation per protein after stimulation  phosphorylation per protein before stimulation)/phosphorylation per
protein before stimulation. *P < 0.05 vs. RET-PTC-1, t test.
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